Neoplasms

Blood and Lymph Conditions

Immune System Diseases

All Conditions

Rare Diseases

Lymphoma

Lymphoma, Non-Hodgkin

Neoplasms by Histologic Type

Lymphoproliferative Disorders

Lymphatic Diseases

Immunoproliferative Disorders

Lymphosarcoma

Anti-Infective Agents

Antineoplastic Agents

All Drugs and Chemicals

Antirheumatic Agents

Dermatologic Agents

Reproductive Control Agents

Micronutrients

Hematinics

Vitamins

Cytarabine

Methotrexate

Rituximab

Thiotepa

Carmustine

Antineoplastic Agents, Immunological

Immunologic Factors

Antimetabolites

Enzyme Inhibitors

Folic Acid

Vitamin B Complex

Folic Acid Antagonists

Immunosuppressive Agents

Antiviral Agents

Antineoplastic Agents, Alkylating

Alkylating Agents

Folinic Acid

Folate

Vitamin B9

first diagnosis of PCNSL: combined chemotherapy with methotrexate

Patients with relapse or progressive disease of PCNSL after methotrexate containing chemotherapy

methotrexate

3000mg/m2 die i.v., 2 days (max. 2 cycles)

40mg/m2 i.v. (max. 2 cycles) 2 x 5mg/kg/die i.v. for 2 days

Carmustin

Gerald Illerhaus, Dr.

Andreas Zähringer, Dr.

Andreas Zähringer

Jürgen Finke, Prof. Dr.

The purpose of this study is to determine whether combined chemotherapy \[rituximab plus high dosage methotrexate (max. 2 cycles) followed by arabinoside/thiotepa (max. 2 cycles) followed by high dosage carmustin/thiotepa\] followed by peripheral blood stem cell transplantation is effective in the treatment of cerebral Non Hodgkin lymphoma \[PCNSL\].

Freiburg ZNS-NHL Study

Freiburg ZNS-NHL Study: Therapy for Patients With Primary Non-Hodgkin Lymphoma of the CNS - Sequential High Dosage Chemotherapy With Autologous Peripheral Blood Stem Cell Plantation

University Hospital Tuebingen

University Hospital Freiburg

Dr. G. Illerhaus

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Freiburg ZNS-NHL Study	NCT00647049	Primary Non Hod...	methotrexate Rituximab Cytarabine Thiotepa Carmustin	18 Years - 65 Years	University Hospital Freiburg
Freiburg ZNS-NHL Study	NCT00647049	Primary Non Hod...	methotrexate Rituximab Cytarabine Thiotepa Carmustin	18 Years - 65 Years	University Hospital Freiburg

Spots Global Cancer Trial Database for carmustin

Every month we try and update this database with for carmustin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for carmustin

Every month we try and update this database with for carmustin cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for carmustin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.